Post-streptococcal glomerulonephritis natural history, complications and prognosis

Revision as of 17:40, 14 June 2018 by Manpreet Kaur (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Post-streptococcal glomerulonephritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Post-streptococcal glomerulonephritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Post-streptococcal glomerulonephritis natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Post-streptococcal glomerulonephritis natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Post-streptococcal glomerulonephritis natural history, complications and prognosis

CDC on Post-streptococcal glomerulonephritis natural history, complications and prognosis

Post-streptococcal glomerulonephritis natural history, complications and prognosis in the news

Blogs on Post-streptococcal glomerulonephritis natural history, complications and prognosis

Directions to Hospitals Treating Post-streptococcal glomerulonephritis

Risk calculators and risk factors for Post-streptococcal glomerulonephritis natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]

Overview

The symptoms of post-streptococcal glomerulonephritis typically develop one to three weeks after exposure to group A streptococcal throat infection and 3 to 6 weeks after group A streptococcal skin infection. Common complications of post-streptococcal glomerulonephritis include severe nephritis, renal failure , atypical hemolytic uremic syndrome , refractory hypoxic respiratory failure, and seizures. Prognosis is generally excellent but depends upon age and co-morbidities.

Natural History, Complications, and Prognosis

Natural History

Complications

Common complications of post-streptococcal glomerulonephritis include:[2][3][4]

Prognosis

  • Prognosis is generally excellent.[5][6]
  • Some people develop recurrent proteinuria and renal dysfunction 10 to 40 years after the presentation.[7]
  • Age and presence of comorbidities are the most important prognostic factors for PSGN.
  • Children have an excellent prognosis with a <1% rate of azotemia, and a 3-10% rate of non-nephrotic range proteinuria, microhematuria, and hypertension.
  • The prognosis of PSGN in children might vary depending on individual co-morbidities, such as diabetes, obesity, and low birth weight.[5]
  • Elderly patients with PSGN who often have co-morbidities have a comparatively much poorer prognosis with a 60% rate of azotemia, 40% rate of congestive heart failure, and 20% rate of nephrotic syndrome.[8][9]

References

  1. Ayoob RM, Schwaderer AL (2016). "Acute Kidney Injury and Atypical Features during Pediatric Poststreptococcal Glomerulonephritis". Int J Nephrol. 2016: 5163065. doi:10.1155/2016/5163065. PMC 5011525. PMID 27642522.
  2. Kakajiwala A, Bhatti T, Kaplan BS, Ruebner RL, Copelovitch L (February 2016). "Post-streptococcal glomerulonephritis associated with atypical hemolytic uremic syndrome: to treat or not to treat with eculizumab?". Clin Kidney J. 9 (1): 90–6. doi:10.1093/ckj/sfv119. PMC 4720198. PMID 26798467.
  3. Mara-Koosham G, Stoltze K, Aday J, Rendon P (2016). "Pulmonary Renal Syndrome After Streptococcal Pharyngitis: A Case Report". J Investig Med High Impact Case Rep. 4 (2): 2324709616646127. doi:10.1177/2324709616646127. PMC 4871206. PMID 27231692.
  4. Adikari M, Priyangika D, Marasingha I, Thamotheram S, Premawansa G (September 2014). "Post-streptococcal glomerulonephritis leading to posterior reversible encephalopathy syndrome: a case report". BMC Res Notes. 7: 644. doi:10.1186/1756-0500-7-644. PMC 4175190. PMID 25218027.
  5. 5.0 5.1 Rodriguez-Iturbe B, Musser JM (October 2008). "The current state of poststreptococcal glomerulonephritis". J. Am. Soc. Nephrol. 19 (10): 1855–64. doi:10.1681/ASN.2008010092. PMID 18667731.
  6. Tejani A, Ingulli E (1990). "Poststreptococcal glomerulonephritis. Current clinical and pathologic concepts". Nephron. 55 (1): 1–5. doi:10.1159/000185909. PMID 2191230.
  7. Pinto SW, Sesso R, Vasconcelos E, Watanabe YJ, Pansute AM (August 2001). "Follow-up of patients with epidemic poststreptococcal glomerulonephritis". Am. J. Kidney Dis. 38 (2): 249–55. doi:10.1053/ajkd.2001.26083. PMID 11479149.
  8. Melby PC, Musick WD, Luger AM, Khanna R (1987). "Poststreptococcal glomerulonephritis in the elderly. Report of a case and review of the literature". Am J Nephrol. 7 (3): 235–40. PMID 3631152.
  9. Washio M, Oh Y, Okuda S, Yanase T, Miishima C, Fujimi S; et al. (1994). "Clinicopathological study of poststreptococcal glomerulonephritis in the elderly". Clin Nephrol. 41 (5): 265–70. PMID 8050205.

Template:WH